Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Taketo Ichinose is active.

Publication


Featured researches published by Taketo Ichinose.


International Journal of Urology | 2010

Tension‐free vaginal mesh procedure for pelvic organ prolapse: A single‐center experience of 310 cases with 1‐year follow up

Satoru Takahashi; Daisuke Obinata; Takahiro Sakuma; Yusuke Nagane; Katsuhiko Sato; Junichi Mochida; Taketo Ichinose; Kenya Yamaguchi

Objective:  To prospectively evaluate the efficacy of a tension‐free vaginal mesh (TVM) procedure for pelvic organ prolapse (POP).


Medical Molecular Morphology | 2009

A case of solitary fibrous tumor of the kidney: an immunohistochemical and ultrastructural study with a review of the literature

Daisaku Hirano; Aya Mashiko; Yasutaka Murata; K. Satoh; Taketo Ichinose; Satoru Takahashi; Toyoharu Jike; Masahiko Sugitani

A solitary fibrous tumor (SFT) is an unusual spindle cell neoplasm that usually arises in the pleura but rarely occurs in the kidney. Despite its rarity, histological diagnosis of SFT is crucial to avoid misdiagnosis with other malignant tumors in the kidney. We report a SFT of the left kidney that presented as a malignant tumor on radiographic findings in a 75-year-old Japanese woman. The tumor was well circumscribed and composed of a mixture of spindle cells and dense collagenous bands with no areas of necrosis or cystic changes noted macroscopically or microscopically. Electron microscopy showed fibroblast-like cells with well-developed rough endoplasmic reticulum, surrounded with collagen fibers. Immunohistochemistry revealed reactivity for vimentin, CD34, Bcl-2, and CD99, but no staining for cytokeratin, S-100, desmin, actin, D2-40, or epithelial membrane antigen (EMA). These findings were compatible with those of SFT. Although SFT of the kidney is extremely rare, this tumor must be included in the differential diagnosis when we encounter renal tumors consisting of mesenchymal elements. Immunohistochemical study is the key to diagnosis for SFT, and ultrastructural study is useful for its diagnosis.


International Journal of Urology | 2008

How do symptoms have an impact on the prognosis of renal cell carcinoma

Nozomu Kawata; Yusuke Nagane; Kenya Yamaguchi; Taketo Ichinose; Hitoshi Hirakata; Satoru Takahashi

Aim:  Symptomatic renal cell carcinoma (RCC) is well known to have a characteristic behavior. We therefore evaluated the impact of systemic symptoms on the prognosis of RCC.


International Journal of Urology | 2006

Prostate-specific antigen failure within 2 years of radical prostatectomy predicts overall survival

Takahiko Hachiya; Taketo Ichinose; Hitoshi Hirakata; Nozomu Kawata; Kiyoki Okada; Yukie Takimoto

Objective:  This study attempts to determine whether prostate‐specific antigen (PSA) failure following radical retropubic prostatectomy (RRP) affects patients’ long‐term overall survival.


International Journal of Urology | 2006

Usefulness of contrast-enhanced ultrasound for the diagnosis of recurrent renal cell carcinoma in contralateral kidney.

Nozomu Kawata; Takumi Igarashi; Taketo Ichinose; Hitoshi Hirakata; Takahiko Hachiya; Yukie Takimoto; Masahiro Ogawa

Abstract  We studied contrast‐enhanced ultrasound (CEU) for recurrence of renal cell carcinoma (RCC) at the contralateral kidney during postoperative follow up of localized renal cell carcinoma. CEU successfully detected all recurring cases, despite the fact that 5/6 cases were observed using conventional ultrasound; the remaining one case was not detected using conventional ultrasound. CEU using Levovisto successfully revealed renal tumors as RCC. Lesions were diagnosed as cystic renal tumors by Bosniac classification, and pathological findings demonstrated RCC, in accordance with the prior tumor.


Luts: Lower Urinary Tract Symptoms | 2010

Effects of α1‐Blockers for Lower Urinary Tract Symptoms and Sleep Disorders in Patients with Benign Prostatic Hyperplasia

Takahiro Sakuma; Katsuhiko Sato; Yusuke Nagane; Junichi Mochida; Shuji Sugimoto; Taketo Ichinose; Kenya Yamaguchi; Makoto Uchiyama; Satoru Takahashi

Objectives: We evaluated the association of lower urinary tract symptoms (LUTS) and sleep disorders (SD) in patients with benign prostatic hyperplasia (BPH). We also examined improvement of SD following the α1‐blocker therapy for LUTS.


Urology | 2007

Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.

Nozomu Kawata; Yusuke Nagane; Hitoshi Hirakata; Taketo Ichinose; Yasuhiro Okada; Kenya Yamaguchi; Satoru Takahashi


Urology | 2006

Strong significant correlation between MMP-9 and systemic symptoms in patients with localized renal cell carcinoma

Nozomu Kawata; Yusuke Nagane; Takumi Igarashi; Hitoshi Hirakata; Taketo Ichinose; Takahiko Hachiya; Yukie Takimoto; Satoru Takahashi


Urology | 2007

Primary Malignant Melanoma of the Female Urethra

Tsuyoshi Yoshizawa; Nozomu Kawata; Katsuhiko Sato; Hitoshi Hirakata; Takumi Igarashi; Taketo Ichinose; Kenya Yamaguchi; Satoru Takahashi


International Urology and Nephrology | 2010

Neoadjuvant LHRH analog plus estramustine phosphate combined with three-dimensional conformal radiotherapy for intermediate- to high-risk prostate cancer: a randomized study

Daisaku Hirano; Yusuke Nagane; K. Satoh; Junichi Mochida; Shuji Sugimoto; Taketo Ichinose; Satoru Takahashi; Toshiya Maebayashi; Tsutomu Saitoh

Collaboration


Dive into the Taketo Ichinose's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge